- Poster presentation
- Open Access
Laboratorial significance of autoantibodies of dense fine speckled pattern
© Castro and Piotto; licensee BioMed Central Ltd. 2012
- Published: 13 July 2012
- Complete Blood Count
- Positive Test
- Indirect Immunofluorescence
- Antinuclear Antibody
Indirect immunofluorescence (IIF) in Hep-2 cells is the standard screening test for antinuclear antibodies (ANA). Advances in this methodology have brought up a considerable increase in sensitivity and consequently a decrease in its specificity. This has resulted in an increasing number of positive tests in apparently healthy subjects. In particular, autoantibodies associated with the dense fine speckled (DSF) ANA-Hep-2 pattern, has been largely detected in apparently healthy individuals.
ANA-Hep-2 test from 921 children aged 0.2 to 13.9 years was retrospectively retrieved from the routine of a large private laboratory on-site certified by the College of American Pathologists (CAP). Criteria for patient selection included concomitant existence of at least, one or more of the following tests (complete blood count, erythrocyte hemossedimentation rate [ESR], C - reactive protein [CRP], ferritin, protein electrophoresis and urinalysis). The frequency of ANA-Hep-2 patterns was analyzed according to alterations in those exams. Statistical analysis included Fisher’s exact test, Analysis of Variance (ANOVA), Kruskal-Wallis test, Mann-Whitney test with Bonferroni correction and Kolmogorov-Smirnov test.
Immunofluoresence patterns of antinuclear antibodies
Dense Fine Specified
The DFS pattern was a frequent finding in the ANA-Hep-2 routine and its occurrence was not associated with abnormalities in general laboratory tests. This finding supports the notion that the autoantibodies associated with the DSF ANA-Hep-2 pattern are common in individuals with no apparent health abnormality.
Tania Caroline Castro: None; Daniela Petry Piotto: None.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.